Spotlight on Geriatrics
Influenza: Reducing Complications in High-Risk Patients Through Advanced Treatment Options – Curbside Consult: Treating Flu in a 69-year-old Patient With COPD
StartActivity Details
/ABIM MOC
Expires: June 28, 2021
Accredited By
This continuing medical education activity is provided by
Target Audience
The intended audience for the activity is allergists, immunologists, family practice physicians, general practice physicians, internists, pulmonologists, nurse practitioners, physician assistants, and other health care professionals involved in the management of patients with influenza.
Learning Objectives
Upon successful completion of the activity, participants should be better able to:
- Incorporate revised guidelines into practice to improve earlier detection and treatment of patients with influenza and comorbid respiratory conditions.
- Compare influenza antiviral treatments in terms of their efficacy, safety, and ability to reduce viral shedding and infection in others.
- Incorporate the most appropriate therapeutic regimen in patients with influenza who are at high risk for complications.
Activity Description
In this educational program, expert faculty will discuss strategies for incorporating the latest information regarding the diagnosis and treatment of influenza into practice. Using challenging case-based examples, faculty will provide guidance on selecting the most appropriate therapeutic regimen to reduce morbidity and mortality in patients with influenza who are at high risk for complications.
Faculty
Paul G. Auwaerter, MD, MBA, FIDSA
Sherrilyn and Ken Fisher Professor of Medicine
Clinical Director, Division of Infectious Diseases
Director, Sherrilyn and Ken Fisher Center for Environmental Infectious Diseases
Johns Hopkins University School of Medicine
Baltimore, MD
- Disclosure:
- Consulting Fee: Advanced Biotherapeutics, DiaSorin
- Ownership Interest: Johnson & Johnson
John J. Russell, MD
Clinical Professor of Family and Community Medicine
Thomas Jefferson University
Sidney Kimmel School of Medicine
Philadelphia, PA
Chair, Department of Family Medicine
Program Director, Family Medicine Residency
Abington – Jefferson Health
Abington, PA
- Disclosure:
- Consulting Fee: GlaxoSmithKline, Sanofi Pasteur
- Speakers Bureau: Sanofi Pasteur
Reviewers:
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
Disclosure: No relevant financial relationships to
disclose.
Ronald A. Codario, Jr., MD
Disclosure: No relevant financial relationships to
disclose.
Vindico Medical Education Staff:
Disclosure: No relevant financial relationships to
disclose.
Signed Disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.
Agenda
Curbside Consult: Treating Flu in a 69-year-old Patient With
COPD
Paul G. Auwaerter, MD, MBA, FIDSA and John J. Russell, MD
Conflict of Interest Policy/Disclosure Statement
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all accredited providers are required to mitigate and disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of accredited content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the past 12 months with a commercial interest whose products or services are discussed in the accredited activity content over which the individual has control. Relationship information appears above.
Accreditation Statement
Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Designation of Credit
Vindico Medical Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this
CME activity enables the participant to earn up to 0.25 MOC points in the
American Board of Internal Medicine’s (ABIM) Maintenance of Certification
(MOC) program. Participants who opt-in will earn MOC points equivalent to the
amount of CME credits claimed for the activity. It is the CME activity
provider’s responsibility to submit participant completion information to
ACCME for the purpose of granting ABIM MOC points.
Nurse practitioners can apply for AMA PRA Category 1 Credit(s)™ through the American Academy of Nurse Practitioners Certification Board (AANPCB). AANPCB will accept AMA PRA Category 1 Credit(s)™ from organizations accredited by Accreditation Council for Continuing Medical Education.
Physician assistants participating in the enduring activity can apply for AMA PRA Category 1 Credit(s)™ through the American Academy of Physician Assistants (AAPA). AAPA will accept AMA PRA Category 1 Credit(s)™ from organizations accredited by the ACCME.
Instructions for Receiving Credit
To participate in this CME activity, you must read the objectives, answer the pretest questions, view the CME content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 100% of the posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ Certificate.
Statement of Commercial Support
This activity is supported by an educational grant from Genentech, Inc.
Disclaimer Statement/Disclosure of Unlabeled Use
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non‒FDA-approved or investigational use of products/devices.
Copyright Statement
Created and published by Vindico Medical Education, 6900 Grove Road,
Building 100, Thorofare, NJ
CME Questions?
Contact us at CME@VindicoCME.com
Activity Details
/ABIM MOC
Expires: June 28, 2021
Accredited By
This continuing medical education activity is provided by
Target Audience
The intended audience for the activity is allergists, immunologists, family practice physicians, general practice physicians, internists, pulmonologists, nurse practitioners, physician assistants, and other health care professionals involved in the management of patients with influenza.
Learning Objectives
Upon successful completion of the activity, participants should be better able to:
- Incorporate revised guidelines into practice to improve earlier detection and treatment of patients with influenza and comorbid respiratory conditions.
- Compare influenza antiviral treatments in terms of their efficacy, safety, and ability to reduce viral shedding and infection in others.
- Incorporate the most appropriate therapeutic regimen in patients with influenza who are at high risk for complications.
Activity Description
In this educational program, expert faculty will discuss strategies for incorporating the latest information regarding the diagnosis and treatment of influenza into practice. Using challenging case-based examples, faculty will provide guidance on selecting the most appropriate therapeutic regimen to reduce morbidity and mortality in patients with influenza who are at high risk for complications.
Faculty
Paul G. Auwaerter, MD, MBA, FIDSA
Sherrilyn and Ken Fisher Professor of Medicine
Clinical Director, Division of Infectious Diseases
Director, Sherrilyn and Ken Fisher Center for Environmental Infectious Diseases
Johns Hopkins University School of Medicine
Baltimore, MD
- Disclosure:
- Consulting Fee: Advanced Biotherapeutics, DiaSorin
- Ownership Interest: Johnson & Johnson
John J. Russell, MD
Clinical Professor of Family and Community Medicine
Thomas Jefferson University
Sidney Kimmel School of Medicine
Philadelphia, PA
Chair, Department of Family Medicine
Program Director, Family Medicine Residency
Abington – Jefferson Health
Abington, PA
- Disclosure:
- Consulting Fee: GlaxoSmithKline, Sanofi Pasteur
- Speakers Bureau: Sanofi Pasteur
Reviewers:
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
Disclosure: No relevant financial relationships to
disclose.
Ronald A. Codario, Jr., MD
Disclosure: No relevant financial relationships to
disclose.
Vindico Medical Education Staff:
Disclosure: No relevant financial relationships to
disclose.
Signed Disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.
Agenda
Curbside Consult: Treating Flu in a 69-year-old Patient With
COPD
Paul G. Auwaerter, MD, MBA, FIDSA and John J. Russell, MD
Conflict of Interest Policy/Disclosure Statement
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all accredited providers are required to mitigate and disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of accredited content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the past 12 months with a commercial interest whose products or services are discussed in the accredited activity content over which the individual has control. Relationship information appears above.
Accreditation Statement
Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Designation of Credit
Vindico Medical Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this
CME activity enables the participant to earn up to 0.25 MOC points in the
American Board of Internal Medicine’s (ABIM) Maintenance of Certification
(MOC) program. Participants who opt-in will earn MOC points equivalent to the
amount of CME credits claimed for the activity. It is the CME activity
provider’s responsibility to submit participant completion information to
ACCME for the purpose of granting ABIM MOC points.
Nurse practitioners can apply for AMA PRA Category 1 Credit(s)™ through the American Academy of Nurse Practitioners Certification Board (AANPCB). AANPCB will accept AMA PRA Category 1 Credit(s)™ from organizations accredited by Accreditation Council for Continuing Medical Education.
Physician assistants participating in the enduring activity can apply for AMA PRA Category 1 Credit(s)™ through the American Academy of Physician Assistants (AAPA). AAPA will accept AMA PRA Category 1 Credit(s)™ from organizations accredited by the ACCME.
Instructions for Receiving Credit
To participate in this CME activity, you must read the objectives, answer the pretest questions, view the CME content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 100% of the posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ Certificate.
Statement of Commercial Support
This activity is supported by an educational grant from Genentech, Inc.
Disclaimer Statement/Disclosure of Unlabeled Use
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non‒FDA-approved or investigational use of products/devices.
Copyright Statement
Created and published by Vindico Medical Education, 6900 Grove Road,
Building 100, Thorofare, NJ
CME Questions?
Contact us at CME@VindicoCME.com
Geriatrics Presentations
Managing COPD for the Long Term: Pitfalls and Pearls
StartActivity Details
Expires: January 7, 2022
Accredited By
This continuing nursing education activity is provided by
Target Audience
The intended audience for this activity is long-term care directors of nursing, advance practice nurses, nurses and other health care professionals involved in the management of patients with chronic obstructive pulmonary disease (COPD).
Learning Objectives
Upon successful completion of this activity, participants should be better able to:
- Incorporate the use of Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines and recommendations when assessing and managing patients with COPD.
- Evaluate clinical data on the safety and efficacy profiles of established and emerging medications for the treatment of COPD.
- Select the most appropriate inhalation delivery system for COPD medications based on efficacy, ease of use, as well as patient characteristics and preferences.
Activity Description
Chronic obstructive pulmonary disease is often underdiagnosed and undertreated—contributing to chronic morbidity and mortality worldwide. Due to the advanced age of many patients with COPD, patient adherence to treatment can be a significant challenge—especially for COPD patients in long-term care settings. Diagnostic and treatment algorithms for patients with COPD, such as those from the GOLD report, continue to be updated as management protocols are optimized. Furthermore, new and emerging therapies, along with innovative delivery devices, look to address patient adherence and provide a more personalized therapeutic approach to enhance quality-of-life measures and clinical outcomes in these patients. In this enduring educational activity, a panel of experts will provide direction for the incorporation of the GOLD guidelines, along with recommendations for the assessment and management of patients with COPD in long-term care. The faculty also will discuss effective delivery of established and emerging medications based on efficacy, ease of use, and patient characteristics.
Agenda
Introduction
Daniel Haimowitz, MD, FACP, CMD
Using GOLD Guidelines in the Long-term Care Setting
Charles Michael Bobbitt, MSN, RN, CDONA
Case Presentation: Classifying COPD
Daniel Haimowitz, MD, FACP, CMD
Treating COPD for the Long Term: Medications and Their Delivery
Alanna Breckenridge, PharmD, BCGP
Case Presentation: COPD Rx
Daniel Haimowitz, MD, FACP, CMD
Activity Chair
Multi-facility Medical Director
Private Practice
Levittown, PA
Disclosure:
No relevant financial relationships to disclose.
Faculty
Nursing Faculty
El Centro College
Dallas County Community College District
Dallas, TX
Disclosure:
No relevant financial relationships to disclose.
Transition of Care Clinical Pharmacist
Northside Hospital Forsyth
Cumming, GA
Disclosure:
Consulting Fee: American Society of Health-System Pharmacists, Sunovion
Reviewers:
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
Disclosure: No relevant financial relationships to disclose.
Barbara A. Niedz, PhD, RN, CPHQ
Disclosure:
Consulting Fee: Beckton Dickinson
Contracted Research: Beckton Dickinson
Vindico Medical Education Staff:
Disclosure: No relevant financial relationships to disclose.
Signed Disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.
Conflict of Interest Policy/Disclosure Statement
In accordance with the American Nurses Credentialing Center’s Standards for Commercial Support, all accredited providers are required to mitigate and disclose to the activity audience the relevant financial relationships of the planners, faculty, and reviewers involved in the development of accredited content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the past 12 months with a commercial interest whose products or services are discussed in the accredited activity content over which the individual has control. Relationship information is accurate at the time of content development.
Accreditation Statement
Vindico Medical Education is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
Designation of Credit
Vindico Medical Education will provide a maximum of 0.75 contact hours for nurses. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
This activity is
approved for 0.75 contact hour(s) of continuing education (which includes
0.42 hours of pharmacology) by the American Association of Nurse
Practitioners. Activity ID 20124658. This activity was planned in accordance
with AANP Accreditation Standards and Policies.
Instructions for Receiving Credit
To participate in this CNE activity, you must read the objectives, answer the pretest questions, view the content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 2 out of 3 of the posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue a Contact Hour Certificate.
Statement of Commercial Support
This activity is supported by an educational grant from Sunovion Pharmaceuticals Inc.
There is no non-commercial support for this activity.
Education activities are distinguished as separate from endorsement of commercial products. When commercial products are displayed, participants will be advised that accredited status as a provider refers only to its continuing education activities and does not imply ANCC Commission on Accreditation endorsement of any commercial products.
Unlabeled and Investigational Usage
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.
Copyright Statement
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2021 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.
CNE Questions?
Contact us at CME@VindicoCME.com
Activity Details
Expires: January 7, 2022
Accredited By
This continuing nursing education activity is provided by
Target Audience
The intended audience for this activity is long-term care directors of nursing, advance practice nurses, nurses and other health care professionals involved in the management of patients with chronic obstructive pulmonary disease (COPD).
Learning Objectives
Upon successful completion of this activity, participants should be better able to:
- Incorporate the use of Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines and recommendations when assessing and managing patients with COPD.
- Evaluate clinical data on the safety and efficacy profiles of established and emerging medications for the treatment of COPD.
- Select the most appropriate inhalation delivery system for COPD medications based on efficacy, ease of use, as well as patient characteristics and preferences.
Activity Description
Chronic obstructive pulmonary disease is often underdiagnosed and undertreated—contributing to chronic morbidity and mortality worldwide. Due to the advanced age of many patients with COPD, patient adherence to treatment can be a significant challenge—especially for COPD patients in long-term care settings. Diagnostic and treatment algorithms for patients with COPD, such as those from the GOLD report, continue to be updated as management protocols are optimized. Furthermore, new and emerging therapies, along with innovative delivery devices, look to address patient adherence and provide a more personalized therapeutic approach to enhance quality-of-life measures and clinical outcomes in these patients. In this enduring educational activity, a panel of experts will provide direction for the incorporation of the GOLD guidelines, along with recommendations for the assessment and management of patients with COPD in long-term care. The faculty also will discuss effective delivery of established and emerging medications based on efficacy, ease of use, and patient characteristics.
Agenda
Introduction
Daniel Haimowitz, MD, FACP, CMD
Using GOLD Guidelines in the Long-term Care Setting
Charles Michael Bobbitt, MSN, RN, CDONA
Case Presentation: Classifying COPD
Daniel Haimowitz, MD, FACP, CMD
Treating COPD for the Long Term: Medications and Their Delivery
Alanna Breckenridge, PharmD, BCGP
Case Presentation: COPD Rx
Daniel Haimowitz, MD, FACP, CMD
Activity Chair
Multi-facility Medical Director
Private Practice
Levittown, PA
Disclosure:
No relevant financial relationships to disclose.
Faculty
Nursing Faculty
El Centro College
Dallas County Community College District
Dallas, TX
Disclosure:
No relevant financial relationships to disclose.
Transition of Care Clinical Pharmacist
Northside Hospital Forsyth
Cumming, GA
Disclosure:
Consulting Fee: American Society of Health-System Pharmacists, Sunovion
Reviewers:
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
Disclosure: No relevant financial relationships to disclose.
Barbara A. Niedz, PhD, RN, CPHQ
Disclosure:
Consulting Fee: Beckton Dickinson
Contracted Research: Beckton Dickinson
Vindico Medical Education Staff:
Disclosure: No relevant financial relationships to disclose.
Signed Disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.
Conflict of Interest Policy/Disclosure Statement
In accordance with the American Nurses Credentialing Center’s Standards for Commercial Support, all accredited providers are required to mitigate and disclose to the activity audience the relevant financial relationships of the planners, faculty, and reviewers involved in the development of accredited content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the past 12 months with a commercial interest whose products or services are discussed in the accredited activity content over which the individual has control. Relationship information is accurate at the time of content development.
Accreditation Statement
Vindico Medical Education is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
Designation of Credit
Vindico Medical Education will provide a maximum of 0.75 contact hours for nurses. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
This activity is
approved for 0.75 contact hour(s) of continuing education (which includes
0.42 hours of pharmacology) by the American Association of Nurse
Practitioners. Activity ID 20124658. This activity was planned in accordance
with AANP Accreditation Standards and Policies.
Instructions for Receiving Credit
To participate in this CNE activity, you must read the objectives, answer the pretest questions, view the content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 2 out of 3 of the posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue a Contact Hour Certificate.
Statement of Commercial Support
This activity is supported by an educational grant from Sunovion Pharmaceuticals Inc.
There is no non-commercial support for this activity.
Education activities are distinguished as separate from endorsement of commercial products. When commercial products are displayed, participants will be advised that accredited status as a provider refers only to its continuing education activities and does not imply ANCC Commission on Accreditation endorsement of any commercial products.
Unlabeled and Investigational Usage
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.
Copyright Statement
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2021 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.
CNE Questions?
Contact us at CME@VindicoCME.com
Influenza: Reducing Complications in High-Risk Patients Through Advanced Treatment Options – Curbside Consult: Treating Flu in a 69-year-old Patient With COPD
StartActivity Details
/ABIM MOC
Expires: June 28, 2021
Accredited By
This continuing medical education activity is provided by
Target Audience
The intended audience for the activity is allergists, immunologists, family practice physicians, general practice physicians, internists, pulmonologists, nurse practitioners, physician assistants, and other health care professionals involved in the management of patients with influenza.
Learning Objectives
Upon successful completion of the activity, participants should be better able to:
- Incorporate revised guidelines into practice to improve earlier detection and treatment of patients with influenza and comorbid respiratory conditions.
- Compare influenza antiviral treatments in terms of their efficacy, safety, and ability to reduce viral shedding and infection in others.
- Incorporate the most appropriate therapeutic regimen in patients with influenza who are at high risk for complications.
Activity Description
In this educational program, expert faculty will discuss strategies for incorporating the latest information regarding the diagnosis and treatment of influenza into practice. Using challenging case-based examples, faculty will provide guidance on selecting the most appropriate therapeutic regimen to reduce morbidity and mortality in patients with influenza who are at high risk for complications.
Faculty
Paul G. Auwaerter, MD, MBA, FIDSA
Sherrilyn and Ken Fisher Professor of Medicine
Clinical Director, Division of Infectious Diseases
Director, Sherrilyn and Ken Fisher Center for Environmental Infectious Diseases
Johns Hopkins University School of Medicine
Baltimore, MD
- Disclosure:
- Consulting Fee: Advanced Biotherapeutics, DiaSorin
- Ownership Interest: Johnson & Johnson
John J. Russell, MD
Clinical Professor of Family and Community Medicine
Thomas Jefferson University
Sidney Kimmel School of Medicine
Philadelphia, PA
Chair, Department of Family Medicine
Program Director, Family Medicine Residency
Abington – Jefferson Health
Abington, PA
- Disclosure:
- Consulting Fee: GlaxoSmithKline, Sanofi Pasteur
- Speakers Bureau: Sanofi Pasteur
Reviewers:
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
Disclosure: No relevant financial relationships to
disclose.
Ronald A. Codario, Jr., MD
Disclosure: No relevant financial relationships to
disclose.
Vindico Medical Education Staff:
Disclosure: No relevant financial relationships to
disclose.
Signed Disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.
Agenda
Curbside Consult: Treating Flu in a 69-year-old Patient With
COPD
Paul G. Auwaerter, MD, MBA, FIDSA and John J. Russell, MD
Conflict of Interest Policy/Disclosure Statement
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all accredited providers are required to mitigate and disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of accredited content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the past 12 months with a commercial interest whose products or services are discussed in the accredited activity content over which the individual has control. Relationship information appears above.
Accreditation Statement
Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Designation of Credit
Vindico Medical Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this
CME activity enables the participant to earn up to 0.25 MOC points in the
American Board of Internal Medicine’s (ABIM) Maintenance of Certification
(MOC) program. Participants who opt-in will earn MOC points equivalent to the
amount of CME credits claimed for the activity. It is the CME activity
provider’s responsibility to submit participant completion information to
ACCME for the purpose of granting ABIM MOC points.
Nurse practitioners can apply for AMA PRA Category 1 Credit(s)™ through the American Academy of Nurse Practitioners Certification Board (AANPCB). AANPCB will accept AMA PRA Category 1 Credit(s)™ from organizations accredited by Accreditation Council for Continuing Medical Education.
Physician assistants participating in the enduring activity can apply for AMA PRA Category 1 Credit(s)™ through the American Academy of Physician Assistants (AAPA). AAPA will accept AMA PRA Category 1 Credit(s)™ from organizations accredited by the ACCME.
Instructions for Receiving Credit
To participate in this CME activity, you must read the objectives, answer the pretest questions, view the CME content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 100% of the posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ Certificate.
Statement of Commercial Support
This activity is supported by an educational grant from Genentech, Inc.
Disclaimer Statement/Disclosure of Unlabeled Use
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non‒FDA-approved or investigational use of products/devices.
Copyright Statement
Created and published by Vindico Medical Education, 6900 Grove Road,
Building 100, Thorofare, NJ
CME Questions?
Contact us at CME@VindicoCME.com
Activity Details
/ABIM MOC
Expires: June 28, 2021
Accredited By
This continuing medical education activity is provided by
Target Audience
The intended audience for the activity is allergists, immunologists, family practice physicians, general practice physicians, internists, pulmonologists, nurse practitioners, physician assistants, and other health care professionals involved in the management of patients with influenza.
Learning Objectives
Upon successful completion of the activity, participants should be better able to:
- Incorporate revised guidelines into practice to improve earlier detection and treatment of patients with influenza and comorbid respiratory conditions.
- Compare influenza antiviral treatments in terms of their efficacy, safety, and ability to reduce viral shedding and infection in others.
- Incorporate the most appropriate therapeutic regimen in patients with influenza who are at high risk for complications.
Activity Description
In this educational program, expert faculty will discuss strategies for incorporating the latest information regarding the diagnosis and treatment of influenza into practice. Using challenging case-based examples, faculty will provide guidance on selecting the most appropriate therapeutic regimen to reduce morbidity and mortality in patients with influenza who are at high risk for complications.
Faculty
Paul G. Auwaerter, MD, MBA, FIDSA
Sherrilyn and Ken Fisher Professor of Medicine
Clinical Director, Division of Infectious Diseases
Director, Sherrilyn and Ken Fisher Center for Environmental Infectious Diseases
Johns Hopkins University School of Medicine
Baltimore, MD
- Disclosure:
- Consulting Fee: Advanced Biotherapeutics, DiaSorin
- Ownership Interest: Johnson & Johnson
John J. Russell, MD
Clinical Professor of Family and Community Medicine
Thomas Jefferson University
Sidney Kimmel School of Medicine
Philadelphia, PA
Chair, Department of Family Medicine
Program Director, Family Medicine Residency
Abington – Jefferson Health
Abington, PA
- Disclosure:
- Consulting Fee: GlaxoSmithKline, Sanofi Pasteur
- Speakers Bureau: Sanofi Pasteur
Reviewers:
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
Disclosure: No relevant financial relationships to
disclose.
Ronald A. Codario, Jr., MD
Disclosure: No relevant financial relationships to
disclose.
Vindico Medical Education Staff:
Disclosure: No relevant financial relationships to
disclose.
Signed Disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.
Agenda
Curbside Consult: Treating Flu in a 69-year-old Patient With
COPD
Paul G. Auwaerter, MD, MBA, FIDSA and John J. Russell, MD
Conflict of Interest Policy/Disclosure Statement
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all accredited providers are required to mitigate and disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of accredited content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the past 12 months with a commercial interest whose products or services are discussed in the accredited activity content over which the individual has control. Relationship information appears above.
Accreditation Statement
Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Designation of Credit
Vindico Medical Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this
CME activity enables the participant to earn up to 0.25 MOC points in the
American Board of Internal Medicine’s (ABIM) Maintenance of Certification
(MOC) program. Participants who opt-in will earn MOC points equivalent to the
amount of CME credits claimed for the activity. It is the CME activity
provider’s responsibility to submit participant completion information to
ACCME for the purpose of granting ABIM MOC points.
Nurse practitioners can apply for AMA PRA Category 1 Credit(s)™ through the American Academy of Nurse Practitioners Certification Board (AANPCB). AANPCB will accept AMA PRA Category 1 Credit(s)™ from organizations accredited by Accreditation Council for Continuing Medical Education.
Physician assistants participating in the enduring activity can apply for AMA PRA Category 1 Credit(s)™ through the American Academy of Physician Assistants (AAPA). AAPA will accept AMA PRA Category 1 Credit(s)™ from organizations accredited by the ACCME.
Instructions for Receiving Credit
To participate in this CME activity, you must read the objectives, answer the pretest questions, view the CME content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 100% of the posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ Certificate.
Statement of Commercial Support
This activity is supported by an educational grant from Genentech, Inc.
Disclaimer Statement/Disclosure of Unlabeled Use
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non‒FDA-approved or investigational use of products/devices.
Copyright Statement
Created and published by Vindico Medical Education, 6900 Grove Road,
Building 100, Thorofare, NJ
CME Questions?
Contact us at CME@VindicoCME.com